This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Hal Corwin, MD; William DeMyer, MD

Arch Neurol. 1980;37(6):347-349.

Abstract
• Clorazepate dipotassium (Tranxene), an anticonvulsant benzodiazepine, was tested for teratogenicity by injecting ten pregnant Long-Evans rats with 32 mg/kg of body weight intramuscularly on days 8.5, 9.5, and 10.5 of gestation. Ten control rats similarly received sterile water injections. Sixty fetuses recovered after killing five of the mothers on day 20.5 of gestation were sectioned to ascertain external and visceral malformations. Comparison with 55 control fetuses showed no statistically significant differences in external, visceral, or skeletal malformations, nor in fetal mortality, fetal and placental weight, and crown-rump length. Five clorazepate-treated rat mothers were allowed to deliver their 45 offspring for a companion study of possible behavioral effects. None of these additional 45 clorazepate-treated rats showed external malformations. Thus, clorazepate caused no gross malformations in the rat under the conditions of this study.

Author Affiliations
From the Neuroanatomy Laboratory, Department of Neurology, Indiana University School of Medicine, Indianapolis.

Footnotes
Accepted for publication May 21, 1979.

Reprint requests to Department of Neurology, Indiana University School of Medicine, 1100 W Michigan St, Indianapolis, IN 46223 (Dr DeMyer).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?